Largest pharmaceutical companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Viatris has the lowest figure of the 61 pharmaceutical companies ranked by earnings, at -CHF 3B, followed by Insmed (-CHF 1.1B) and Summit Therapeutics (-CHF 910.6M). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Viatris-CHF 3B
- Median
- CHF 49.8M
- Combined market value
- CHF 4.29T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ViatrisVTRS · Health Care | -CHF 3B | CHF 19.9B | CHF 17.35 | 0.56% up | 96% up | ||
| 2 | InsmedINSM · Health Care | -CHF 1.1B | CHF 22.3B | CHF 101.46 | 1.28% down | 40% down | ||
| 3 | Summit TherapeuticsSMMT · Health Care | -CHF 910.6M | CHF 7.2B | CHF 8.95 | 0.56% down | 36% down | ||
| 4 | Takeda PharmaceuticalTAK · Health Care | -CHF 805M | CHF 57.6B | CHF 18.03 | 1.22% down | 54% up | ||
| 5 | CytokineticsCYTK · Health Care | -CHF 662.1M | CHF 6B | CHF 43.22 | 0.78% down | 20% down | ||
| 6 | BridgeBio PharmaBBIO · Health Care | -CHF 618.2M | CHF 12.8B | CHF 65.49 | 1.11% up | 17% up | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | -CHF 321.7M | CHF 3.9B | CHF 23.12 | 1.67% up | 64% down | ||
| 8 | ABIVAXABVX · Health Care | -CHF 314.5M | CHF 6.2B | CHF 70.52 | 1.84% up | 27% down | ||
| 9 | Jazz PharmaceuticalsJAZZ · Health Care | -CHF 300.4M | CHF 13.2B | CHF 205.91 | 1.42% up | 37% up | ||
| 10 | Cogent BiosciencesCOGT · Health Care | -CHF 277.4M | CHF 4.1B | CHF 23.83 | 1.45% up | 20% down | ||
| 11 | Praxis Precision MedicinesPRAX · Health Care | -CHF 255.8M | CHF 7.2B | CHF 257.58 | 0.11% up | 61% up | ||
| 12 | Roivant SciencesROIV · Health Care | -CHF 252.8M | CHF 23.5B | CHF 32.45 | 0.62% down | 90% up | ||
| 13 | Legend BiotechLEGN · Health Care | -CHF 250.3M | CHF 2.7B | CHF 13.69 | 0.74% up | 42% down | ||
| 14 | Madrigal PharmaceuticalsMDGL · Health Care | -CHF 243.2M | CHF 7.9B | CHF 341.99 | 3.91% down | 24% down | ||
| 15 | Ascendis PharmaASND · Health Care | -CHF 213.4M | CHF 15B | CHF 228.63 | 0.04% down | 28% up | ||
| 16 | Elanco Animal HealthELAN · Health Care | -CHF 195.7M | CHF 11.2B | CHF 22.32 | 2.36% up | 20% up | ||
| 17 | Rhythm PharmaceuticalsRYTM · Health Care | -CHF 165.8M | CHF 6.8B | CHF 98.74 | 0.39% up | 13% up | ||
| 18 | Definium TherapeuticsDFTX · Health Care | -CHF 155M | CHF 3.3B | CHF 24.11 | 2.72% down | 169% up | ||
| 19 | Axsome TherapeuticsAXSM · Health Care | -CHF 154.5M | CHF 5.9B | CHF 112.97 | 1.48% down | 7% down | ||
| 20 | Edgewise TherapeuticsEWTX · Health Care | -CHF 141.5M | CHF 3.8B | CHF 34.75 | 2.00% down | 88% up | ||
| 21 | Dianthus TherapeuticsDNTH · Health Care | -CHF 136.9M | CHF 4.1B | CHF 73.15 | 0.29% down | 113% up | ||
| 22 | Spyre TherapeuticsSYRE · Health Care | -CHF 130.9M | CHF 7.6B | CHF 80.47 | 1.69% up | 286% up | ||
| 23 | Protagonist TherapeuticsPTGX · Health Care | -CHF 109.8M | CHF 6.9B | CHF 105.78 | 0.59% up | 46% up | ||
| 24 | ErascaERAS · Health Care | -CHF 105M | CHF 3.9B | CHF 11.06 | 5.62% down | 403% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -CHF 88.9M | CHF 5.5B | CHF 81.38 | 0.18% up | 241% up | ||
| 26 | Belite BioBLTE · Health Care | -CHF 65.5M | CHF 5.4B | CHF 133.37 | 0.26% up | 31% up | ||
| 27 | VeradermicsMANE · Health Care | -CHF 59M | CHF 4.4B | CHF 104.64 | 1.25% down | 233% up | ||
| 28 | Travere TherapeuticsTVTX · Health Care | -CHF 21.5M | CHF 4.1B | CHF 42.43 | 1.56% down | 44% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | -CHF 19.7M | CHF 5B | CHF 77.13 | 0.54% down | 31% up | ||
| 30 | Arrowhead PharmaceuticalsARWR · Health Care | -CHF 1.4M | CHF 5.1B | CHF 36.29 | 0.07% up | 10% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 49.8M | CHF 6.4B | CHF 80.96 | 0.92% up | 126% up | ||
| 32 | Amneal PharmaceuticalsAMRX · Health Care | CHF 60.8M | CHF 6.3B | CHF 18.18 | 2.06% up | 83% up | ||
| 33 | Corcept TherapeuticsCORT · Health Care | CHF 84.1M | CHF 6.3B | CHF 57.40 | 2.88% down | 8% down | ||
| 34 | Ligand PharmaceuticalsLGND · Health Care | CHF 105M | CHF 5.1B | CHF 253.16 | 2.16% up | 43% up | ||
| 35 | AlkermesALKS · Health Care | CHF 203.8M | CHF 6.6B | CHF 39.36 | 2.68% up | 58% up | ||
| 36 | BeOne MedicinesONC · Health Care | CHF 242M | CHF 38.8B | CHF 339.96 | 2.47% down | 17% up | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | CHF 264.6M | CHF 17.1B | CHF 127.88 | 3.12% down | 66% down | ||
| 38 | BioMarin PharmaceuticalBMRN · Health Care | CHF 294.3M | CHF 9.8B | CHF 50.85 | 3.04% up | 11% up | ||
| 39 | GrifolsGRFS · Health Care | CHF 376.2M | CHF 4.9B | CHF 7.18 | 1.33% down | 1% up | ||
| 40 | TG TherapeuticsTGTX · Health Care | CHF 377.2M | CHF 8.3B | CHF 55.06 | 4.10% up | 107% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 384.6M | CHF 10.5B | CHF 12.64 | 1.32% up | 5% up | ||
| 42 | PTC TherapeuticsPTCT · Health Care | CHF 575.8M | CHF 4.3B | CHF 50.90 | 0.02% down | 20% down | ||
| 43 | Royalty PharmaRPRX · Health Care | CHF 650.3M | CHF 33.4B | CHF 58.08 | 0.26% up | 78% up | ||
| 44 | GenmabGMAB · Health Care | CHF 812.2M | CHF 26.6B | CHF 43.18 | 1.46% down | 70% up | ||
| 45 | United TherapeuticsUTHR · Health Care | CHF 1.1B | CHF 20.8B | CHF 488.05 | 0.94% down | 23% up | ||
| 46 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 1.2B | CHF 41.6B | CHF 35.64 | 0.84% down | 74% up | ||
| 47 | ZoetisZTS · Health Care | CHF 2.3B | CHF 28.8B | CHF 70.82 | 0.58% up | 29% down | ||
| 48 | Vertex PharmaceuticalsVRTX · Health Care | CHF 3.3B | CHF 114.5B | CHF 451.47 | 0.20% up | 27% up | ||
| 49 | AbbVieABBV · Health Care | CHF 3.6B | CHF 431.1B | CHF 243.88 | 1.26% down | 26% up | ||
| 50 | Regeneron PharmaceuticalsREGN · Health Care | CHF 3.8B | CHF 83.4B | CHF 806.64 | 0.15% down | 36% up | ||
| 51 | Abbott LaboratoriesABT · Health Care | CHF 5.5B | CHF 153.3B | CHF 88.51 | 0.22% up | 17% down | ||
| 52 | Bristol-Myers SquibbBMY · Health Care | CHF 5.9B | CHF 103.8B | CHF 50.78 | 1.86% down | 34% up | ||
| 53 | GSKGSK · Health Care | CHF 6.4B | CHF 82.5B | CHF 41.15 | 0.91% down | 6% up | ||
| 54 | PfizerPFE · Health Care | CHF 6.6B | CHF 135.5B | CHF 23.77 | 1.00% down | 14% up | ||
| 55 | SanofiSNY · Health Care | CHF 7.3B | CHF 95.8B | CHF 39.91 | 0.45% down | 4% down | ||
| 56 | AstraZenecaAZN · Health Care | CHF 8.6B | CHF 234.5B | CHF 151.23 | 1.63% down | 2% up | ||
| 57 | NovartisNVS · Health Care | CHF 11.8B | CHF 248.4B | CHF 131.51 | 2.02% down | 25% up | ||
| 58 | Novo NordiskNVO · Health Care | CHF 12.8B | CHF 147B | CHF 33.35 | 2.85% down | 17% down | ||
| 59 | Merck & CoMRK · Health Care | CHF 15.4B | CHF 290.4B | CHF 117.78 | 2.60% down | 51% up | ||
| 60 | Eli LillyLLY · Health Care | CHF 17.4B | CHF 1.04T | CHF 1,169.38 | 2.06% down | 35% up | ||
| 61 | Johnson & JohnsonJNJ · Health Care | CHF 22.6B | CHF 559.9B | CHF 232.59 | 1.05% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8435 CHF).
Questions and answers
Which pharmaceutical companies have the lowest earnings?
Viatris (-CHF 3B), Insmed (-CHF 1.1B) and Summit Therapeutics (-CHF 910.6M) have the lowest earnings of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 16:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by earnings.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by earnings have a combined market value of CHF 4.29T as of 18 Nov 2026, 16:47 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.